Column Group III GP LP insider trades
Open-market stock purchases and sales by Column Group III GP LP, Unknown at Surrozen, Inc./DE, from SEC Form 4 filings since Aug 3, 2021.
Track record: 81% of 48 scored buys are up 5% or more since purchase, averaging +45%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $5.6M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $6.4M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $6M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $8.5M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $9.5M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $9M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $2.8M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $3.2M |
| Oct 20, 2026 | SRZN Surrozen, Inc./DE | Bought (not open market) | $3M |
| Feb 25, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $928K |
| Feb 25, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $1M |
| Feb 24, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $190K |
| Feb 24, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $215K |
| Feb 23, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $85.8K |
| Feb 23, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $96.9K |
| Feb 20, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $151K |
| Feb 20, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $171K |
| Feb 11, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $1.3M |
| Feb 11, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $1.5M |
| Feb 10, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $132K |
| Feb 10, 2026 | TNYA Tenaya Therapeutics, Inc | Sold | $149K |
| Jan 20, 2026 | SRZN Surrozen, Inc./DE | Bought | $166K |
| Jan 20, 2026 | SRZN Surrozen, Inc./DE | Bought | $188K |
| Jan 16, 2026 | SRZN Surrozen, Inc./DE | Bought | $24.1K |
| Jan 16, 2026 | SRZN Surrozen, Inc./DE | Bought | $27.2K |
Get free alerts when Column Group III GP LP files a new trade →